Meeting
2022 ASCO Quality Care Symposium
Patterns of molecular testing and targeted therapy use among privately insured patients with cancer.
Authors
Xuanzi Qin
Vanderbilt University School of Medicine, Nashville, TN
Xuanzi Qin, Stacie B Dusetzina
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Cost, Value, and Policy,Health Care Access, Equity, and Disparities,Patient Experience
Sub Track
Access to Treatment
Citation
J Clin Oncol 40, 2022 (suppl 28; abstr 133)
DOI
10.1200/JCO.2022.40.28_suppl.133
Abstract #
133
Poster Bd #
E2
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Quality Care Symposium
Impact of the COVID-19 pandemic on administration of systemic therapy in the Medicare population.
First Author: Peter Kardel
First Author: Devashish Desai
Poster
2022 ASCO Annual Meeting
Insights of clinical significance from solid tumor profiles with FoundationOne CDx.
First Author: Andreas M Heilmann
Poster
2019 ASCO Annual Meeting
Racial disparities in cancer survival: A trend analysis based on SEER data (1973-2010).
First Author: Seyed Navid Alavi